+1 213-510-3499 sales@vparesearch.com
+1 213-510-3499 sales@vparesearch.com
Home/ Healthcare
Industry Coverage

Healthcare Market Research & Reports

Healthcare is being revolutionized by telemedicine, AI‑assisted diagnostics, precision therapeutics, and value‑based care models. VPA Research provides exhaustive analyses of pharmaceutical pipelines, medical device innovation, digital health platforms, and hospital service trends. We track regulatory pathways (FDA, EMA), reimbursement shifts, and patient engagement strategies impacting adoption rates. With granular forecasts by therapy area, device type, and delivery model, our insights support life sciences companies, providers, payers, and investors in navigating a complex, patient‑centric healthcare landscape.

Latest Reports in Healthcare

Explore syndicated research, market outlooks, and sector-specific analysis curated for strategy and growth teams.

2457 reports available

Antibody Specificity Testing Market Size, Share and Growth Outlook, 2026: Analysis By Offering Type (Products , Testing and Validation Services), By Technology (Immunoassay-based Technologies , Genetic Validation-based Technologies , Microarray-based Technologies, Mass Spectrometry-based Proteomics), By Application (Drug Discovery & Development, Proteomics & Biomarker Discovery, Clinical Diagnostics ), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Diagnostic Laboratories) Companies, and Country Forecast, 2021 to 2034

Global Antibody Specificity Testing Market size is forecast to increase from $1.15 Billion in 2026 to $2.04 Billion in 2034 at a CAGR of 7.44% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005637
Pages: 224 Pages

Antibody Production Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Monoclonal Antibodies , Polyclonal Antibodies , Antibody-Drug Conjugates , Bispecific , Antibody Fragments ), By Production Type (In Vitro Production , In Vivo Production ), By Application (Therapeutic Applications, Diagnostic Applications, Research Applications), By End-User (Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, Academic & Research Institutes, Contract Manufacturing Organizations) Companies, and Country Forecast, 2021 to 2034

Global Antibody Production Market size is forecast to increase from $24.84 Billion in 2026 to $64.19 Billion in 2034 at a CAGR of 12.6% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005636
Pages: 219 Pages

Antibody Optimization Service Market Size, Share and Growth Outlook, 2026: Analysis By Service Type (Affinity Maturation, Humanization, Fc Engineering , Stability & Aggregation Optimization, Sequence , De-immunization, Isotype ), By Technology (Phage Display, Yeast Display, Mammalian Display, Ribosome , AI-based & Computational Optimization), By Application (Oncology, Autoimmune & Inflammatory Diseases, Infectious Diseases, Cardiovascular Diseases, Neurological Disorders), By End-User (Pharmaceutical & Biotechnology Companies, Contract Research & Manufacturing Organizations , Academic & Research Institutes) Companies, and Country Forecast, 2021 to 2034

Global Antibody Optimization Service Market size is forecast to increase from $2.69 Billion in 2026 to $5.24 Billion in 2034 at a CAGR of 8.7% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005635
Pages: 211 Pages

Antibody Fragments Market Size, Share and Growth Outlook, 2026: Analysis By Fragment Type (Fab , scFv , sdAb , Dual-Fragment Formats , Diabodies & Multimers), By Specificity (Monoclonal Antibody Fragments, Polyclonal Antibody Fragments), By Production Method (Bacterial Expression Systems , Yeast Expression Systems, Mammalian Cell Culture, Phage Display & Cell-Free Platforms), By End User (Biopharmaceutical & Biotechnology Companies, Contract Research & Manufacturing Organizations , Diagnostic Laboratories, Academic & Research Institutes) Companies, and Country Forecast, 2021 to 2034

Global Antibody Fragments Market size is forecast to increase from $9.73 Billion in 2026 to $15.28 Billion in 2034 at a CAGR of 5.8% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005634
Pages: 223 Pages

Antibody Drug Conjugates (ADC) Market Size, Share and Growth Outlook, 2026: Analysis By Approved Product (Trastuzumab Deruxtecan , Trastuzumab Emtansine , Enfortumab Vedotin , Brentuximab Vedotin , Sacituzumab Govitecan , Mirvetuximab Soravtansine , Polatuzumab Vedotin , Others), By Payload Class (Topoisomerase I Inhibitors, Microtubule Inhibitors, DNA-Damaging / Alkylating Agents, Emerging Payloads), By Linker Chemistry (Cleavable Linkers , Non-Cleavable Linkers), By Conjugation Technology (Conventional Conjugation , Site-Specific Conjugation), By Indication (Breast Cancer, Lung Cancer , Hematologic Malignancies , Urothelial / Bladder Cancer, Gynecologic Cancers , Others), By End-User (Hospitals, Specialized Cancer Centers & Infusion Clinics, Biopharma & Contract Research Organizations) Companies, and Country Forecast, 2021 to 2034

Global Antibody Drug Conjugates (ADC) Market size is forecast to increase from $8.76 Billion in 2026 to $22.96 Billion in 2034 at a CAGR of 12.8% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005633
Pages: 212 Pages

Antibody Drug Conjugates (ADC) Contract Manufacturing Market Size, Share and Growth Outlook, 2026: Analysis By Service Type (Antibody Manufacturing, Payload/Toxin Synthesis, Linker Manufacturing, Conjugation and Purification, Fill-Finish Operations, Analytical Testing & Quality Control), By Linker Type (Cleavable Linkers , Non-cleavable Linkers), By Development Stage (Preclinical, Clinical , Commercial), By Therapeutic Area (Oncology , Autoimmune Diseases, Infectious Diseases, Metabolic Disorders), By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes) Companies, and Country Forecast, 2021 to 2034

Global Antibody Drug Conjugates (ADC) Contract Manufacturing Market size is forecast to increase from $26.83 Billion in 2026 to $60.07 Billion in 2034 at a CAGR of 10.6% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005632
Pages: 217 Pages

Antibody Discovery Services Market Size, Share and Growth Outlook, 2026: Analysis By Discovery Technology (Hybridoma Technology, Phage Display Technology, Single-B-Cell Screening, Transgenic Animal Platforms, Others, AI/ML-Enabled In-Silico Design), By Service (Target Identification & Validation, Antigen Design & Production, Hit Generation & Lead Selection, Antibody Engineering & Lead Optimization), By Nature of Antibody (Human Antibodies, Humanized & Chimeric Antibodies, Murine Antibodies, Next-Gen Scaffolds ), By Therapeutic Area (Oncology & Immuno-oncology, Autoimmune & Inflammatory Diseases, Infectious Diseases, Neurology & Cardiovascular Disorders), By End-User (Pharmaceutical & Biotechnology Companies, Biotechnology Start-ups, Contract Research & Manufacturing Organizations , Academic & Research Institutes) Companies, and Country Forecast, 2021 to 2034

Global Antibody Discovery Services Market size is forecast to increase from $2.58 Billion in 2026 to $6.57 Billion in 2034 at a CAGR of 12.4% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005631
Pages: 217 Pages

Antibody Contract Development and Manufacturing Organization Market Size, Share and Growth Outlook, 2026: Analysis By Service Type (Process Development & Optimization, Drug Substance Manufacturing , Fill-Finish & Drug Product Manufacturing, Analytical Testing & Quality Control Services), By Antibody (Monoclonal Antibodies , Bispecific / Multispecific Antibodies, Antibody-Drug Conjugates , Polyclonal Antibodies, Antibody Fragments), By Scale of Operation (Clinical Stage Manufacturing , Commercial Stage Manufacturing), By Therapeutic Area (Oncology, Immunology & Autoimmune Diseases, Neurology / Central Nervous System , Infectious Diseases, Cardiovascular & Metabolic Diseases), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes) Companies, and Country Forecast, 2021 to 2034

Global Antibody Contract Development and Manufacturing Organization Market size is forecast to increase from $26.83 Billion in 2026 to $54.25 Billion in 2034 at a CAGR of 9.2% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005630
Pages: 226 Pages

Antibodies Contract Manufacturing Market Size, Share and Growth Outlook, 2026: Analysis By Type of Antibody Manufactured (Monoclonal Antibodies (mAbs), Bispecific , Antibody-Drug Conjugates (ADCs), Antibody Fragments ), By Product Type (Active Pharmaceutical Ingredients , Finished Dosage Forms ), By Expression System Used (Mammalian Cell Culture Systems, Microbial Fermentation Systems), By Scale of Operation (Preclinical , Commercial Scale Production), By Therapeutic Area (Oncological Disorders, Autoimmune & Inflammatory Disorders, Infectious Diseases, Cardiovascular Disorders, Neurological Disorders, Metabolic & Genetic Disorders) Companies, and Country Forecast, 2021 to 2034

Global Antibodies Contract Manufacturing Market size is forecast to increase from $23.69 Billion in 2026 to $56.19 Billion in 2034 at a CAGR of 11.4% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005629
Pages: 220 Pages

Antibiotics Market Size, Share and Growth Outlook, 2026: Analysis By Product Class (Cephalosporins, Penicillins, Fluoroquinolones, Macrolides, Carbapenems, Aminoglycosides, Sulfonamides, Tetracyclines), By Drug Origin (Synthetic Antibiotics, Natural , Semi-Synthetic Antibiotics), By Spectrum of Activity (Broad-Spectrum Antibiotics, Narrow-Spectrum Antibiotics), By Therapy Type (Monotherapies, Combination Therapies), By Route of Administration (Oral, Intravenous (IV), Intramuscular, Topical) Companies, and Country Forecast, 2021 to 2034

Global Antibiotics Market size is forecast to increase from $60.54 Billion in 2026 to $82.22 Billion in 2034 at a CAGR of 3.9% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005628
Pages: 212 Pages